A B S T R A C T Tumor-promoting phorbol diesters were shown to suppress natural killing in vitro by human peripheral blood mononuclear cells. The inhibitory effect of different phorbol diesters and their analogues correlated with their potency as tumor promoters, the most effective agent being 12-0-tetradecanoylphorbol-13-acetate (TPA). Both peripheral blood cells and targets specifically bound TPA, and natural killing could be inhibited by pretreatment of either cell population with TPA, though this was less effective than direct addition of TPA to the assay. Cells that had been pretreated with TPA released TPA and metabolites of TPA during subsequent incubation in fresh medium. This release of TPA was evidently responsible for the inhibition of natural killing by pretreated target cells; in experiments where labeled and unlabeled target cells were mixed, pretreatment of unlabeled targets with TPA inhibited killing of labeled targets. Suppression of natural killing by TPA was greatly reduced when adherent cells were removed from the peripheral blood cells, suggesting that monocytes mediate suppression. Inhibition of natural killing by TPA provides a model for examining the regulation of natural killing. Suppression of natural killing by phorbol diesters may contribute to their activity as tumor promoters.
INTRODUCTION
Natural killing refers to the rapid cellular lysis of certain tumor cell lines (and even certain normal cells) without prior sensitization to the target (1) (2) (3) . This spontaneous cytotoxicity is mediated by a distinct subgroup of mononuclear cells called natural killer (NK)' cells (1, 2) . NK cells lack the features of mature T cells, B cells, or macrophages (1, 2, 4), though a portion of human NK cells binds weakly to sheep erythrocytes, suggesting an association with T cells (5) . Most NK cells in human peripheral blood bear Fc receptors, but natural killing is not primarily dependent on antibody nor on the Fc receptor (6) (7) (8) .
Natural killing has been implicated in host defense against malignancy. Enhancement of natural killing in mice protects against implanted tumor cells (9), and strain differences in natural killing correlate with resistance to tumors that are NK targets (10) . Mice and humans that are congenitally deficient in natural killing are susceptible to certain tumors (11, 12) .
Tumor promoters are agents that are not directly carcinogenic, but which facilitate the induction of tumors by other agents (13) (14) (15) ). An example is the promotion of benzo(a) pyrene-induced skin cancer in mice by the topical application ofcroton oil (16) . The tumor-promoting capacity ofcroton oil is due to phorbol diesters (PD), particularly 12-O-tetradecanoylphorbol- 13-acetate (TPA) (17) . There is evidence that PD promote malignant transformation directly, i.e., independent of effects on host defense. Thus, PD tumor promoters increase the transformation in culture of normal cells by benzo(a)pyrene, malignant viruses, or ultraviolet irradiation (18) (19) (20) . They also alter the cytoskeletal structure of cultured cells (21, 22) and may inhibit or accelerate differentiation of certain cell lines (23, 24) . In the absence of other agents, tumor promoters can induce neoplastic transformation offibroblasts from humans with a genetic predisposition to cancer (hereditary adenomatosis of the colon and rectum) (25) .
PD might also promote malignancy by reducing host defense. Until recently, however, evidence suggested that PD enhance tumor killing. Thus, PD tumor promoters increase killing by activated macrophages and by polymorphonuclear leukocytes through the generation of reactive forms of oxygen (26) (27) (28) . PD tumor promoters are also mitogenic for a subpopulation of human T lymphocytes (29) , but the activity of these cells in host defense is not known. Because Media. All cell preparations were performed in RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.); this was supplemented with 1% fetal bovine serum (FBS, Sterile Systems, Inc., Logan, Utah). For assessment of natural killing, medium was supplemented with 20% FBS, 2 mM glutamine, 5 mM HEPES-buffer (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid), 100 ug/ml penicillin, 100 jug/ml streptomycin, and 0.25 ,ug/ml fungizone ("complete" medium).
Peripheral blood mononuclear cells. Effector cells were obtained from heparinized whole blood by sedimentation onto Ficoll-Hypaque. The cells were washed thrice and viability was then determined by exclusion of trypan blue.
Natural killing was assessed against K562, a myelogenous leukemia cell line grown in suspension culture in RPMI 1640 supplemented with 10% FBS (30) . K562 target cells were labeled by incubation in Na2 [5' Cr]04 (51Cr, carrier free; New England Nuclear) for 1 h, using 100 ,Ci/107 cells in a volume of 0.5 ml. The targets were washed thrice and resuspended to 2 x 105 live cells/ml. Target cells (0.1 ml) were mixed with PBMC (0.1 ml) in round-bottom microtiter plates (tissue culture grade; Linbro Chemical Co., New Haven, Conn.), with effector cells in varying concentration to give effector:target cell ratios as noted. Triplicate samples were prepared for each ratio. The plates were centrifuged at 100g for 3 min, incubated in 5% CO2 at 37°C for 3 h, and then centrifuged at 500 g for 10 min at 4°C. One-half the supernate was withdrawn for determination of released 51Cr by use of a gamma spectrometer. Spontaneous release was determined by the use of unlabeled K562 target cells as effectors. Maximum release was determined by incubation of target cells in saponin (7 mg/ml) and EDTA (0.1 mg/ml). (31) . The chromatograms were cut into 1-cm strips and radioactivity determined. TPA migrated with mobility on chromatography relative to the solvent front (RF) = 0.7-0.8, phorbol monoesters with RF = 0.1-0.4, and phorbol with RF = 0.0, as described by O'Brien and Diamond (31) .
Inhibition of natural killing by supernates from cells pretreated with TPA. PBMC or K562 were pretreated with TPA at varying concentrations as above, washed thrice, and resuspended to 107 cells/ml in complete medium. Aliquots of 0.2 ml (2 x 10c cells) were incubated at 37°C for 1 h. The cells were then pelleted at 500 g for 10 min and one-half the super- suppression of killing when TPA was added at the start of the assay.
nate was withdrawn to test for suppression of natural killing by addition to a mixture of fresh PBMC and targets.
Removal of adherent cells. Adherent and nonadherent PBMC were separated by the method of Ackerman and Douglas (32) . Briefly P388DI (murine macrophage) cells were grown to confluence in 75-cm2 tissue culture flasks (Costar 3075, Costar Packaging, Cambridge, Mass.) and then removed by exposure to 10 mM EDTA for 15 min at 20°C. PBMC were incubated on these conditioned flasks (2 x 107 cells per flask) for 1 h at 37°C in 5% CO2. Nonadherent cells were removed by decanting. Cell recovery was 50-60%. Adherent cells were recovered by incubation in EDTA (32) . Monocytes were identified by morphology and esterase staining, according to the method of Yam et al. (33) .
RESULTS
TPA reduces natural killing by PBMC. As little as 1 ng/ml of TPA was often sufficient to reduce natural kill- ing when added to the incubation mixture at the start of the assay, and a marked reduction was regularly seen with concentrations of 10 ng/ml or more (Fig. 1) . The effect of TPA was demonstrated on PBMC from each of 12 individuals. TPA, in concentrations up to 1,000 ng/ ml, was not toxic to PBMC during the assay as determined either by 51Cr-labeling of the PBMC rather than the targets (Table I) or by exclusion of trypan blue (not shown). When PBMC were incubated overnight in TPA (up to 100 ng/ml) there was still no loss of viable cells when compared to cultures without TPA as assessed by exclusion of trypan blue.
When TPA was added after the start of the assay, the remaining natural killing was inhibited (Table II) . When TPA was added at the end of the assay, no inhibition was seen, demonstrating that TPA does not interfere with the recovery of 5'Cr.
Correlation between inhibition of natural killing and potency of tumor promotion by phorbol diesters. We next examined the inhibition of natural killing by other PD and related compounds, by other tumor promoters, and by nonpromoting substances with inflammatory properties. PDD, a tumor promoter ofmoderate potency, inhibited natural killing at concentrations -100-fold higher than TPA (Fig. 2) . 4a-PDD, an analogue of PDD that is inactive as a tumor promoter, had no effect on natural killing. 4-0-methyl TPA, an analogue of TPA that is relatively weak as a tumor promoter, was inhibitory only at 1,000 times the inhibitory concentration of TPA. Table III summarizes the potency of these agents and several other (relatively weak) tumor promoters with regard to (a) tumor promo- (Fig. 3) . For pretreatment of PBMC, the concentration of TPA required for 50% inhibition was 10-to-100-fold higher than required when TPA was added directly to the assay, whereas for K562 target cells, the concentration required was 1,000-fold higher (Fig. 4) . Pretreat representing about one-third of the total TPA. Almost all of the radioactivity associated with PBMC or K562 was still associated with TPA as determined by chromatographic analysis (Fig. 5 (Fig. 7) . There was rapid release during the first hour, followed by continued, slow release. During the first hour, PBMC released 25% of the total cell-associated radioactivity, whereas targets released -12%. Most of the radioactivity was still associated with TPA, but radioactive metabolites of TPA were found both in cells and in the medium (Fig.  5 , Table IV ). PBMC were more active than K562 in metabolizing TPA. In different experiments, metabolites represented 10-25% of the radioactivity released by PBMC in 1 h. The metabolites were more polar than TPA and are presumably the result of deacylation of TPA, yielding phorbol and phorbol monoesters, which are inactive as tumor promoters.
Despite this partial metabolism of TPA, most of the TPA released by preincubated PBMC or by K562 cells was intact. It might therefore act on untreated cells during the assay for natural killing. To examine this point the supernates from PBMC or K562 pretreated with TPA were added to fresh effectors and targets to test (Table III) .
for suppression of natural killing. The supernates from PBMC were more suppressive than the supernates from K652 (Table V) , consistent with the demonstration that PBMC released more TPA. Killing of labeled targets is inhibited in the presence of unlabeled cells pretreated with TPA. If pretreatment of K562 target cells with TPA inhibited natural killing indirectly, by the release of TPA during the assay, then killing of labeled ("hot") targets should be suppressed in the presence of unlabeled ("cold") tar- gets that had been pretreated with TPA. To test this possibility killing was assessed against a 1:1 mixture of hot and cold targets, with TPA pretreatment of either target. When neither target population was treated with TPA, cold targets blocked natural killing of labeled targets by -50%, as expected. Natural killing was then further reduced equally by pretreatment of Phorbol Diester Tumor Promotors Suppress Natural Killing either the hot or the cold targets with TPA ( Fig. 8) . We conclude that pretreatment of target cells with TPA inhibits natural killing indirectly, i.e., the TPA does not simply make the targets resistant to killing. 9), even at 1,000 ng/ml. In two experiments, some stimulation of killing by nonadherent cells occurred at 0.01-1.0 ng/ml TPA. We do not yet know if this represents natural killing or stimulation of unrelated cytotoxic cells. Adherent cells alone did not usually kill K562 (Fig. 9) , although in some experiments low levels of killing were seen when TPA was present at 10-100
nglml. In separate experiments, suppression was re- (34) , stimulate the release of glycosyltransferases from lymphocytes (35) , alter the course of cell differentiation (23, 24) , and stimulate the release of reactive oxygen groups from macrophages and polymorphonuclear cells (36) (37) (38) . From (41) have shown that hydroperoxidation of arachidonic acid produces a nontoxic suppressor of lymphocyte proliferation and maturation. These findings suggest a role for reactive oxygen species in immune regulation. We are currently investigating the role of reactive oxygen species in the suppression of natural killing by PD.
In reducing natural killing, PD may promote malignancy by reducing host defense. While these studies were in progress, Keller reported that PD tumor promoters reduce natural killing in rats (42), and we have found the same effect in mice (unpublished observations). The in vivo administration of TPA to rats increased their susceptibility to injected tumor cells. These data provide evidence that promotion of malignancy by PD may involve effects on host defense in addition to effects on malignant transformation (42) .
Keller also found that TPA suppressed killing by rat adherent peritoneal cells in a 36-h cytotoxicity assay (42) . This is in contrast to the ability ofTPA to stimulate cytotoxicity by macrophages in a "short-term" (4.5-h) assay, in which killing is mediated by the production of reactive oxygen species (27, 28) . Although TPA stimulates macrophage cytotoxicity in short-term culture, it inhibits natural killing. This suggests that NK cells differ from macrophages in their mechanism of killing or in their susceptibility to the effects of TPA.
We have shown that PBMC and K562 demonstrate both saturable and nonsaturable binding of TPA; for PBMC the saturable binding is complete within 5 min at 37°C and for K562 it is complete at 20 min (Gindhart, T.D., B. Dalal, and W. E. Seaman. Unpublished data). A receptor for TPA has recently been demonstrated in human PBMC (43) . A PD receptor has also been demonstrated in membrane preparations from chick embryo fibroblasts (44) . It is possible that inhibition of natural killing is initiated by binding of PD to a specific cell receptor.
A notable observation in our studies was the ability of PBMC to catabolize TPA to metabolites that are inactive as tumor promoters. PBMC metabolized 10-25% of TPA in 1 h at 37°C. Thus, despite the effects of TPA on natural killing, PBMC are able to detoxify this tumor promoter. The rate of detoxification by PBMC is considerably faster than previously reported for human fibroblasts (31) . Catabolism of TPA may therefore account for the observation that tumor promoters are most effective when given with or after oncogens and that repeated administration of tumor promoters is usually required for maximum effect.
Studies of tumor promoters have primarily focused on their role in malignant transformation. It now appears that PD tumor promoters may also potentiate malignancy by reducing host defense. Inhibition of natural killing by these agents provides a new model for studying the regulation of NK cells. In particular, our findings suggest that NK cells are regulated by monocytes. Abrogation of the effects of tumor promoters on natural killing has a potential role in protection against malignancy.
